WeedPress: The Paper Trail

Operators outside federal registration and the timely-applicant pathway cannot lawfully carry on the activities that require registration. Patients deserve to know whether their dispensaries can keep supplying them.

South Dakota medical cannabis patients could lose access to products they depend on if the businesses growing, making or selling those products lack the federal status required to continue operating. A state license does not settle that question. Where an operator has neither DEA registration nor the protection available to qualifying timely applicants, federal law does not let it carry on the activities requiring registration while it waits for approval.¹

That puts a practical question in front of every patient and family relying on this program: can the dispensary they use keep obtaining the products they buy?

WeedPress reported Friday that a South Dakota industry source described being told by DEA that operators without registration or timely-applicant status “should not be operating.” DEA had not substantively confirmed or clarified that conversation when the report was published. Its written rule and guidance establish the registration requirements independently of the source’s account.²

The reporting reviewed for this article does not establish that a particular patient has already lost access because of that warning. It does establish a reason to ask businesses and public officials for specific answers before a supply problem reaches the dispensary counter.

The supplier’s paperwork can become the patient’s problem

A registered dispensary can still have a supplier problem. DEA warns that dealing outside the authorized federal system can jeopardize the buyer’s application or registration.³

Consider what that could mean for someone who has found a particular oil, edible or other product that works for them. If the dispensary cannot lawfully replenish it from its usual supplier, that patient may have to find an alternative. For someone arranging transportation or helping an elderly parent, a change in availability can mean another trip, another expense and another conversation about treatment.

Those are possible consequences of a supply interruption. WeedPress has not established that they are happening statewide.

Operators that failed to qualify for the transition protection cannot assume that filing a late application lets them keep conducting federally regulated activities. The general registration prohibition remains in place until DEA grants the required registration. Qualifying timely applicants, by contrast, have a regulatory exception allowing covered activity under their state licenses while their applications remain pending.¹

Patients need their dispensaries to explain where they stand.

Ruthie’s already asked the question

On Nov. 2, Ruth Bouza, owner of Ruthie’s Dispensary in Wagner, shared a DEA certificate issued Oct. 30 and asked WeedPress “whom are the medical Cannabis suppliers that I can legally buy from?”⁴

Her question remains useful because it comes from a business that obtained its federal registration and still needed help identifying eligible suppliers.

DEA’s public timely-applicant file cannot provide a named supplier directory. It lists a state, business activity and application control number. It also changes when applicants receive registrations, withdraw or otherwise leave the timely-applicant category. A missing entry does not establish why a business left the list.⁵

WeedPress’s establishment tracker now lists Ruthie’s, Genesis Farms and Pitbull Acres as confirmed DEA registrants. The specific federal activities and locations covered by the Genesis Farms and Pitbull Acres registrations remain to be verified. Their inclusion does not establish that every location or possible transaction is covered.⁶

The tracker also separates confirmed status from unanswered inquiries. A business that has not answered WeedPress may still hold the necessary authorization. Readers should not turn a gap in the reporting into an accusation.

What Nov. 29 means for access

DEA expects timely applicants to establish compliant supply chains by Nov. 29. Eligibility requires a complete, paid April 28–June 26 application still pending and an active state license.³

That date does not make a late applicant eligible to operate in the meantime.

DEA permits timely dispenser and distributor applicants to use certain inventory acquired before its guidance. Already-registered dispensaries are not expressly named. The treatment of deliveries from ineligible suppliers between issuance and Nov. 29 also needs clarification.³

Those unresolved points matter to businesses deciding what they can buy and sell. Patients should receive an explanation of any resulting change in availability.

A state medical cannabis card and a business’s federal registration serve different purposes. South Dakota’s patient process provides a card after certification and application approval. The federal rule separately governs the businesses’ authority to conduct covered activities.¹˒⁷ A patient’s valid card cannot make an unavailable product appear on a shelf.

Ask about the products you actually use

Patients should be able to get a useful answer without learning how to audit a cannabis company.

Before making a trip, ask the dispensary:

• Can you continue obtaining the products I buy? Ask about the particular brand, product and formulation.
• Has your business established its federal status and checked the relevant suppliers? Ask to speak with the person handling compliance if the employee helping you cannot answer.
• Are you expecting any interruption, reduced selection or change in supplier? Ask whether that is a confirmed change or a possibility the business is still investigating.
• How will you tell patients if something changes? Get a working phone number or another reliable way to check availability.

A general assurance should be followed by an explanation when a patient’s usual product may be affected. Businesses do not need to publish sensitive registration identifiers to give customers useful information about availability.

For help with a patient card or application, the South Dakota Office of Medical Cannabis lists 605-773-3361 and MCQuestions@state.sd.us. Questions about changing a treatment product belong with the patient’s clinician.⁷

Patients deserve answers while there is still time to act

On Friday afternoon, WeedPress sent 52 individual status inquiries, follow-ups and supplier-question updates to business addresses, including follow-ups to all 11 addresses contacted Nov. 2. Three addresses returned delivery failures. The tracker identifies those failures and the establishments for which an email address has not been verified. The requested response date is Nov. 10 at 5 p.m. Central.⁸

The questions concern federal status, authorized activities, eligible suppliers and anticipated access problems. A deadline that has not passed is not a missed deadline, and silence is not proof of a violation.

WeedPress has also asked federal and state officials how registered dispensaries can identify eligible suppliers. DEA’s Registration Contact Center opened a case Friday and sent an acknowledgment directing applicants to general registration resources. That acknowledgment did not identify suppliers or answer the question.⁹

The Justice Department said in announcing the first dispensary registrations that state licensure alone does not confer federal registration. It also said manufacturer and distributor applications require additional review.¹⁰ Businesses and officials have had reason to distinguish those credentials. Patients should now be told what the distinction means for continued access.

For an operator outside the required federal framework, continuing as before can carry serious consequences. For the patient, the question is more immediate: will the product be there when they need it?

The industry and the agencies overseeing this transition should answer that while patients can still plan around the information.

If a dispensary has told you a product will become unavailable, refused a purchase, or announced a closure connected to federal requirements, contact weedpressnewstips@gmail.com. Include the business, date and what you were told. Please leave medical records and identification numbers out of an initial message. WeedPress will verify accounts before reporting them.